Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 4-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseases

4-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseases

US Patent 9266848 · Granted Feb 23, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrazolo[3,4-d]pyrimidines as mTOR inhibitors2023
MTOR inhibitor compounds2022
Process for the production of estetrol intermediates2021
Process for the production of estetrol intermediates2021
Heterocyclic compounds and use thereof in medicine and in cosmetics2019
Oxoazetidine derivatives, process for the preparation thereof and use thereof in2017
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treat2017
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treat2016
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treat2016
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treat2016
Benzenesulfonamide compounds, method for synthesizing same, and use thereof in m2016
Benzenesulfonamide compounds, method for synthesizing same, and use thereof in m2016